Prosight Management, LP Adc Therapeutics Sa Put Options Transaction History
Prosight Management, LP
- $281 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ADCT
# of Institutions
84Shares Held
53.9MCall Options Held
5KPut Options Held
7.6K-
Redmile Group, LLC San Francisco, CA15.7MShares$53.9 Million2.32% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.97MShares$20.5 Million0.26% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$12.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.02MShares$10.4 Million0.0% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C32.04MShares$7.01 Million0.18% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $267M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...